Thinking of joining a study?

Register your interest

NCT05440929 | RECRUITING | Metastatic Breast Cancer


Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
Sponsor:

UNC Lineberger Comprehensive Cancer Center

Brief Summary:

I this qualitative study, Investigators will conduct semi-structured interviews with clinicians that are involved in the care of patients with breast cancer to evaluate the acceptability, appropriateness, and feasibility/usability of a metastatic breast cancer-specific prognostic tool. These interviews will be conducted by the UNC CHAI Core and will continue until thematic saturation (estimated 10 participants). The investigators will code the qualitative data using emerging themes, guided by a well-established implementation science theory, the Consolidated Framework for Implementation Research (CFIR). The information gained from these studies will inform an implementation approach to increase the usability and acceptability of a novel prognostic tool to assist oncologists in the prognosis of patients with metastatic breast cancer.

Condition or disease

Metastatic Breast Cancer

End of Life

Intervention/treatment

Clinician Qualitative Interview

Detailed Description:

If this study is successful, Investigators will implement an MBC-specific prognostic tool to help clinicians identify patients who are at high risk of death in the next 30 days. Based on the input from clinicians in this proposal, as well as additional qualitative studies with patients and families, Investigators will design an implementation protocol to inform how to use this tool in clinical practice. Rather than simply publishing a prognostic tool that may not be adopted into practice, this project aims to ensure successful implementation of an evidence-based tool into the routine care of patients with MBC. Doing so will serve as an important step towards identifying high-risk patients and connecting ort to ensure high-quality, patient-centered end-of-life care.

Study Type : OBSERVATIONAL
Estimated Enrollment : 15 participants
Official Title : Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
Actual Study Start Date : 2022-07-15
Estimated Primary Completion Date : 2025-06-10
Estimated Study Completion Date : 2025-07-15

Information not available for Arms and Intervention/treatment

Ages Eligible for Study:
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: 1
Criteria
Inclusion Criteria
  • 1. Verbal informed consent obtained to participate in the study.
  • 2. Subject is willing and able to comply with study procedures based on the judgement of the investigator or protocol designee.
  • 3. Physician, nurse practitioner, physician assistant, or nurse navigator
  • 4. At least 6 months of experience in the clinical care of patients with metastatic breast cancer in the United States.
Exclusion Criteria
  • * Non-English Speaking

Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians

Location Details

NCT05440929


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, North Carolina

University of North Carolina

Chapel Hill, North Carolina, United States, 27599

Loading...